 | • レポートコード：QAF27729 • 出版社/出版日：QYResearch / 2021年4月5日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、140ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の過免疫グロブリン市場について種類別（B型肝炎免疫グロブリン、狂犬病免疫グロブリン、破傷風免疫グロブリン、Rho（D）免疫グロブリン、その他）、用途別（政府機関、民間部門、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・過免疫グロブリン市場の概要 ・世界の主要地域別過免疫グロブリン市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の過免疫グロブリン市場規模2016-2021：種類別（B型肝炎免疫グロブリン、狂犬病免疫グロブリン、破傷風免疫グロブリン、Rho（D）免疫グロブリン、その他） ・世界の過免疫グロブリン市場予測2012-2027：種類別（B型肝炎免疫グロブリン、狂犬病免疫グロブリン、破傷風免疫グロブリン、Rho（D）免疫グロブリン、その他） ・世界の過免疫グロブリン市場規模2016-2021：用途別（政府機関、民間部門、その他） ・世界の過免疫グロブリン市場予測2012-2027：用途別（政府機関、民間部門、その他） ・過免疫グロブリンのアメリカ市場規模と予測2016-2021 ・過免疫グロブリンのヨーロッパ市場規模と予測2016-2021 ・過免疫グロブリンの中国市場規模と予測2016-2021 ・過免疫グロブリンの日本市場規模と予測2016-2021 ・過免疫グロブリンの東南アジア市場規模と予測2016-2021 ・過免疫グロブリンのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （CSL Behring、Grifols、Biotest、Kedrion、CBPO、Emergent (Cangene)、Kamada、CNBG、Hualan Bio、Shanghai RAAS、Sichuan Yuanda Shuyang、ADMA Biologics） ・過免疫グロブリンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・過免疫グロブリンの市場動向・機会・課題 ・調査の結論 |
Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides “passive” immunity to the patient against an agent. This is in contrast to vaccines that provide “active” immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant “passive” short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
Hyperimmune globulin is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides “passive” immunity to the patient against an agent. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
The classification includes the Hepatitis B Immunoglobulins, Rabies Immunoglobulins, Tetanus Immunoglobulins, Rho(D) Immunoglobulins and others, and the revenue proportion of Rho(D) Immunoglobulins in 2019 is about 33%, with the largest market share.
For Hepatitis B Immunoglobulins Market, Asia & Pacific is the largest market, with more than 90% global market share.
For Rabies Immunoglobulins Market, Asia & Pacific is the largest sales market, with more than 85% global market share.
CSL Behring, Grifols, Biotest are the leaders of the industry, with 60% revenue market share in 2019, and hold key technologies and patents. Other manufactures’ products are used to meet local demand. With further expanding market, there will be more players in the future.
Market Analysis and Insights: Global Hyperimmune Globulins Market
The global Hyperimmune Globulins market was valued at US$ 1636.1 in 2020 and will reach US$ 2455.3 million by the end of 2027, growing at a CAGR of 7.0% during 2022-2027.
Global Hyperimmune Globulins Scope and Market Size
The global Hyperimmune Globulins market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hyperimmune Globulins market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Rho(D) Immunoglobulins
Other
Segment by Application
Government Institutions
Private Sector
Other
The Hyperimmune Globulins market is analysed and market size information is provided by regions (countries). Segment by Application, the Hyperimmune Globulins market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
CSL Behring
Grifols
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics
1 Hyperimmune Globulins Market Overview
1.1 Hyperimmune Globulins Product Scope
1.2 Hyperimmune Globulins Segment by Type
1.2.1 Global Hyperimmune Globulins Sales by Type (2016 & 2021 & 2027)
1.2.2 Hepatitis B Immunoglobulins
1.2.3 Rabies Immunoglobulins
1.2.4 Tetanus Immunoglobulins
1.2.5 Rho(D) Immunoglobulins
1.2.6 Other
1.3 Hyperimmune Globulins Segment by Application
1.3.1 Global Hyperimmune Globulins Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Government Institutions
1.3.3 Private Sector
1.3.4 Other
1.4 Hyperimmune Globulins Market Estimates and Forecasts (2016-2027)
1.4.1 Global Hyperimmune Globulins Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Hyperimmune Globulins Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Hyperimmune Globulins Price Trends (2016-2027)
2 Hyperimmune Globulins Estimates and Forecasts by Region
2.1 Global Hyperimmune Globulins Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Hyperimmune Globulins Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Hyperimmune Globulins Sales Market Share by Region (2016-2021)
2.2.2 Global Hyperimmune Globulins Revenue Market Share by Region (2016-2021)
2.3 Global Hyperimmune Globulins Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Hyperimmune Globulins Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Hyperimmune Globulins Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Hyperimmune Globulins Estimates and Projections (2016-2027)
2.4.2 Europe Hyperimmune Globulins Estimates and Projections (2016-2027)
2.4.3 China Hyperimmune Globulins Estimates and Projections (2016-2027)
2.4.4 Japan Hyperimmune Globulins Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Hyperimmune Globulins Estimates and Projections (2016-2027)
2.4.6 India Hyperimmune Globulins Estimates and Projections (2016-2027)
3 Global Hyperimmune Globulins Competition Landscape by Players
3.1 Global Top Hyperimmune Globulins Players by Sales (2016-2021)
3.2 Global Top Hyperimmune Globulins Players by Revenue (2016-2021)
3.3 Global Hyperimmune Globulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hyperimmune Globulins as of 2020)
3.4 Global Hyperimmune Globulins Average Price by Company (2016-2021)
3.5 Manufacturers Hyperimmune Globulins Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Hyperimmune Globulins Market Size by Type
4.1 Global Hyperimmune Globulins Historic Market Review by Type (2016-2021)
4.1.1 Global Hyperimmune Globulins Sales Market Share by Type (2016-2021)
4.1.2 Global Hyperimmune Globulins Revenue Market Share by Type (2016-2021)
4.1.3 Global Hyperimmune Globulins Price by Type (2016-2021)
4.2 Global Hyperimmune Globulins Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Hyperimmune Globulins Sales Forecast by Type (2022-2027)
4.2.2 Global Hyperimmune Globulins Revenue Forecast by Type (2022-2027)
4.2.3 Global Hyperimmune Globulins Price Forecast by Type (2022-2027)
5 Global Hyperimmune Globulins Market Size by Application
5.1 Global Hyperimmune Globulins Historic Market Review by Application (2016-2021)
5.1.1 Global Hyperimmune Globulins Sales Market Share by Application (2016-2021)
5.1.2 Global Hyperimmune Globulins Revenue Market Share by Application (2016-2021)
5.1.3 Global Hyperimmune Globulins Price by Application (2016-2021)
5.2 Global Hyperimmune Globulins Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Hyperimmune Globulins Sales Forecast by Application (2022-2027)
5.2.2 Global Hyperimmune Globulins Revenue Forecast by Application (2022-2027)
5.2.3 Global Hyperimmune Globulins Price Forecast by Application (2022-2027)
6 North America Hyperimmune Globulins Market Facts & Figures
6.1 North America Hyperimmune Globulins Sales by Company
6.1.1 North America Hyperimmune Globulins Sales by Company (2016-2021)
6.1.2 North America Hyperimmune Globulins Revenue by Company (2016-2021)
6.2 North America Hyperimmune Globulins Sales Breakdown by Type
6.2.1 North America Hyperimmune Globulins Sales Breakdown by Type (2016-2021)
6.2.2 North America Hyperimmune Globulins Sales Breakdown by Type (2022-2027)
6.3 North America Hyperimmune Globulins Sales Breakdown by Application
6.3.1 North America Hyperimmune Globulins Sales Breakdown by Application (2016-2021)
6.3.2 North America Hyperimmune Globulins Sales Breakdown by Application (2022-2027)
7 Europe Hyperimmune Globulins Market Facts & Figures
7.1 Europe Hyperimmune Globulins Sales by Company
7.1.1 Europe Hyperimmune Globulins Sales by Company (2016-2021)
7.1.2 Europe Hyperimmune Globulins Revenue by Company (2016-2021)
7.2 Europe Hyperimmune Globulins Sales Breakdown by Type
7.2.1 Europe Hyperimmune Globulins Sales Breakdown by Type (2016-2021)
7.2.2 Europe Hyperimmune Globulins Sales Breakdown by Type (2022-2027)
7.3 Europe Hyperimmune Globulins Sales Breakdown by Application
7.3.1 Europe 140 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 140 Sales Breakdown by Application (2022-2027)
8 China Hyperimmune Globulins Market Facts & Figures
8.1 China Hyperimmune Globulins Sales by Company
8.1.1 China Hyperimmune Globulins Sales by Company (2016-2021)
8.1.2 China Hyperimmune Globulins Revenue by Company (2016-2021)
8.2 China Hyperimmune Globulins Sales Breakdown by Type
8.2.1 China Hyperimmune Globulins Sales Breakdown by Type (2016-2021)
8.2.2 China Hyperimmune Globulins Sales Breakdown by Type (2022-2027)
8.3 China Hyperimmune Globulins Sales Breakdown by Application
8.3.1 China 315 Sales Breakdown by Application (2016-2021)
8.3.2 China 315 Sales Breakdown by Application (2022-2027)
9 Japan Hyperimmune Globulins Market Facts & Figures
9.1 Japan Hyperimmune Globulins Sales by Company
9.1.1 Japan Hyperimmune Globulins Sales by Company (2016-2021)
9.1.2 Japan Hyperimmune Globulins Revenue by Company (2016-2021)
9.2 Japan Hyperimmune Globulins Sales Breakdown by Type
9.2.1 Japan Hyperimmune Globulins Sales Breakdown by Type (2016-2021)
9.2.2 Japan Hyperimmune Globulins Sales Breakdown by Type (2022-2027)
9.3 Japan Hyperimmune Globulins Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Hyperimmune Globulins Market Facts & Figures
10.1 Southeast Asia Hyperimmune Globulins Sales by Company
10.1.1 Southeast Asia Hyperimmune Globulins Sales by Company (2016-2021)
10.1.2 Southeast Asia Hyperimmune Globulins Revenue by Company (2016-2021)
10.2 Southeast Asia Hyperimmune Globulins Sales Breakdown by Type
10.2.1 Southeast Asia Hyperimmune Globulins Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Hyperimmune Globulins Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Hyperimmune Globulins Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Hyperimmune Globulins Market Facts & Figures
11.1 India Hyperimmune Globulins Sales by Company
11.1.1 India Hyperimmune Globulins Sales by Company (2016-2021)
11.1.2 India Hyperimmune Globulins Revenue by Company (2016-2021)
11.2 India Hyperimmune Globulins Sales Breakdown by Type
11.2.1 India Hyperimmune Globulins Sales Breakdown by Type (2016-2021)
11.2.2 India Hyperimmune Globulins Sales Breakdown by Type (2022-2027)
11.3 India Hyperimmune Globulins Sales Breakdown by Application
11.3.1 India Hyperimmune Globulins Sales Breakdown by Application (2016-2021)
11.3.2 India Hyperimmune Globulins Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Hyperimmune Globulins Business
12.1 CSL Behring
12.1.1 CSL Behring Corporation Information
12.1.2 CSL Behring Business Overview
12.1.3 CSL Behring Hyperimmune Globulins Sales, Revenue and Gross Margin (2016-2021)
12.1.4 CSL Behring Hyperimmune Globulins Products Offered
12.1.5 CSL Behring Recent Development
12.2 Grifols
12.2.1 Grifols Corporation Information
12.2.2 Grifols Business Overview
12.2.3 Grifols Hyperimmune Globulins Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Grifols Hyperimmune Globulins Products Offered
12.2.5 Grifols Recent Development
12.3 Biotest
12.3.1 Biotest Corporation Information
12.3.2 Biotest Business Overview
12.3.3 Biotest Hyperimmune Globulins Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Biotest Hyperimmune Globulins Products Offered
12.3.5 Biotest Recent Development
12.4 Kedrion
12.4.1 Kedrion Corporation Information
12.4.2 Kedrion Business Overview
12.4.3 Kedrion Hyperimmune Globulins Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Kedrion Hyperimmune Globulins Products Offered
12.4.5 Kedrion Recent Development
12.5 CBPO
12.5.1 CBPO Corporation Information
12.5.2 CBPO Business Overview
12.5.3 CBPO Hyperimmune Globulins Sales, Revenue and Gross Margin (2016-2021)
12.5.4 CBPO Hyperimmune Globulins Products Offered
12.5.5 CBPO Recent Development
12.6 Emergent (Cangene)
12.6.1 Emergent (Cangene) Corporation Information
12.6.2 Emergent (Cangene) Business Overview
12.6.3 Emergent (Cangene) Hyperimmune Globulins Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Emergent (Cangene) Hyperimmune Globulins Products Offered
12.6.5 Emergent (Cangene) Recent Development
12.7 Kamada
12.7.1 Kamada Corporation Information
12.7.2 Kamada Business Overview
12.7.3 Kamada Hyperimmune Globulins Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Kamada Hyperimmune Globulins Products Offered
12.7.5 Kamada Recent Development
12.8 CNBG
12.8.1 CNBG Corporation Information
12.8.2 CNBG Business Overview
12.8.3 CNBG Hyperimmune Globulins Sales, Revenue and Gross Margin (2016-2021)
12.8.4 CNBG Hyperimmune Globulins Products Offered
12.8.5 CNBG Recent Development
12.9 Hualan Bio
12.9.1 Hualan Bio Corporation Information
12.9.2 Hualan Bio Business Overview
12.9.3 Hualan Bio Hyperimmune Globulins Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Hualan Bio Hyperimmune Globulins Products Offered
12.9.5 Hualan Bio Recent Development
12.10 Shanghai RAAS
12.10.1 Shanghai RAAS Corporation Information
12.10.2 Shanghai RAAS Business Overview
12.10.3 Shanghai RAAS Hyperimmune Globulins Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Shanghai RAAS Hyperimmune Globulins Products Offered
12.10.5 Shanghai RAAS Recent Development
12.11 Sichuan Yuanda Shuyang
12.11.1 Sichuan Yuanda Shuyang Corporation Information
12.11.2 Sichuan Yuanda Shuyang Business Overview
12.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulins Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Sichuan Yuanda Shuyang Hyperimmune Globulins Products Offered
12.11.5 Sichuan Yuanda Shuyang Recent Development
12.12 ADMA Biologics
12.12.1 ADMA Biologics Corporation Information
12.12.2 ADMA Biologics Business Overview
12.12.3 ADMA Biologics Hyperimmune Globulins Sales, Revenue and Gross Margin (2016-2021)
12.12.4 ADMA Biologics Hyperimmune Globulins Products Offered
12.12.5 ADMA Biologics Recent Development
13 Hyperimmune Globulins Manufacturing Cost Analysis
13.1 Hyperimmune Globulins Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Hyperimmune Globulins
13.4 Hyperimmune Globulins Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Hyperimmune Globulins Distributors List
14.3 Hyperimmune Globulins Customers
15 Market Dynamics
15.1 Hyperimmune Globulins Market Trends
15.2 Hyperimmune Globulins Drivers
15.3 Hyperimmune Globulins Market Challenges
15.4 Hyperimmune Globulins Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Hyperimmune Globulins Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Hyperimmune Globulins Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Hyperimmune Globulins Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Hyperimmune Globulins Sales (K Units) by Region (2016-2021)
Table 5. Global Hyperimmune Globulins Sales Market Share by Region (2016-2021)
Table 6. Global Hyperimmune Globulins Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Hyperimmune Globulins Revenue Share by Region (2016-2021)
Table 8. Global Hyperimmune Globulins Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Hyperimmune Globulins Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Hyperimmune Globulins Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Hyperimmune Globulins Revenue Share Forecast by Region (2022-2027)
Table 12. Global Hyperimmune Globulins Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Hyperimmune Globulins Sales Share by Company (2016-2021)
Table 14. Global Hyperimmune Globulins Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Hyperimmune Globulins Revenue Share by Company (2016-2021)
Table 16. Global Hyperimmune Globulins by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hyperimmune Globulins as of 2020)
Table 17. Global Hyperimmune Globulins Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Hyperimmune Globulins Manufacturing Sites and Area Served
Table 19. Manufacturers Hyperimmune Globulins Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Hyperimmune Globulins Sales (K Units) by Type (2016-2021)
Table 22. Global Hyperimmune Globulins Sales Share by Type (2016-2021)
Table 23. Global Hyperimmune Globulins Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Hyperimmune Globulins Price (USD/Unit) by Type (2016-2021)
Table 25. Global Hyperimmune Globulins Sales Share by Type (2022-2027)
Table 26. Global Hyperimmune Globulins Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Hyperimmune Globulins Revenue Share by Type (2022-2027)
Table 28. Global Hyperimmune Globulins Price (USD/Unit) by Type (2022-2027)
Table 29. Global Hyperimmune Globulins Sales (K Units) by Application (2016-2021)
Table 30. Global Hyperimmune Globulins Sales Share by Application (2016-2021)
Table 31. Global Hyperimmune Globulins Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Hyperimmune Globulins Price (USD/Unit) by Application (2016-2021)
Table 33. Global Hyperimmune Globulins Sales (K Units) by Application (2022-2027)
Table 34. Global Hyperimmune Globulins Sales Share by Application (2022-2027)
Table 35. Global Hyperimmune Globulins Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Hyperimmune Globulins Revenue Share by Application (2022-2027)
Table 37. Global Hyperimmune Globulins Price (USD/Unit) by Application (2022-2027)
Table 38. North America Hyperimmune Globulins Sales (K Units) by Company (2016-2021)
Table 39. North America Hyperimmune Globulins Sales Market Share by Company (2016-2021)
Table 40. North America Hyperimmune Globulins Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Hyperimmune Globulins Revenue Market Share by Company (2016-2021)
Table 42. North America Hyperimmune Globulins Sales by Type (2016-2021) & (K Units)
Table 43. North America Hyperimmune Globulins Sales Market Share by Type (2016-2021)
Table 44. North America Hyperimmune Globulins Sales by Type (2022-2027) & (K Units)
Table 45. North America Hyperimmune Globulins Sales Market Share by Type (2022-2027)
Table 46. North America Hyperimmune Globulins Sales by Application (2016-2021) & (K Units)
Table 47. North America Hyperimmune Globulins Sales Market Share by Application (2016-2021)
Table 48. North America Hyperimmune Globulins Sales by Application (2022-2027) & (K Units)
Table 49. North America Hyperimmune Globulins Sales Market Share by Application (2022-2027)
Table 50. Europe Hyperimmune Globulins Sales (K Units) by Company (2016-2021)
Table 51. Europe Hyperimmune Globulins Sales Market Share by Company (2016-2021)
Table 52. Europe Hyperimmune Globulins Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Hyperimmune Globulins Revenue Market Share by Company (2016-2021)
Table 54. Europe Hyperimmune Globulins Sales by Type (2016-2021) & (K Units)
Table 55. Europe Hyperimmune Globulins Sales Market Share by Type (2016-2021)
Table 56. Europe Hyperimmune Globulins Sales by Type (2022-2027) & (K Units)
Table 57. Europe Hyperimmune Globulins Sales Market Share by Type (2022-2027)
Table 58. Europe Hyperimmune Globulins Sales by Application (2016-2021) & (K Units)
Table 59. Europe Hyperimmune Globulins Sales Market Share by Application (2016-2021)
Table 60. Europe Hyperimmune Globulins Sales by Application (2022-2027) & (K Units)
Table 61. Europe Hyperimmune Globulins Sales Market Share by Application (2022-2027)
Table 62. China Hyperimmune Globulins Sales (K Units) by Company (2016-2021)
Table 63. China Hyperimmune Globulins Sales Market Share by Company (2016-2021)
Table 64. China Hyperimmune Globulins Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Hyperimmune Globulins Revenue Market Share by Company (2016-2021)
Table 66. China Hyperimmune Globulins Sales by Type (2016-2021) & (K Units)
Table 67. China Hyperimmune Globulins Sales Market Share by Type (2016-2021)
Table 68. China Hyperimmune Globulins Sales by Type (2022-2027) & (K Units)
Table 69. China Hyperimmune Globulins Sales Market Share by Type (2022-2027)
Table 70. China Hyperimmune Globulins Sales by Application (2016-2021) & (K Units)
Table 71. China Hyperimmune Globulins Sales Market Share by Application (2016-2021)
Table 72. China Hyperimmune Globulins Sales by Application (2022-2027) & (K Units)
Table 73. China Hyperimmune Globulins Sales Market Share by Application (2022-2027)
Table 74. Japan Hyperimmune Globulins Sales (K Units) by Company (2016-2021)
Table 75. Japan Hyperimmune Globulins Sales Market Share by Company (2016-2021)
Table 76. Japan Hyperimmune Globulins Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Hyperimmune Globulins Revenue Market Share by Company (2016-2021)
Table 78. Japan Hyperimmune Globulins Sales by Type (2016-2021) & (K Units)
Table 79. Japan Hyperimmune Globulins Sales Market Share by Type (2016-2021)
Table 80. Japan Hyperimmune Globulins Sales by Type (2022-2027) & (K Units)
Table 81. Japan Hyperimmune Globulins Sales Market Share by Type (2022-2027)
Table 82. Japan Hyperimmune Globulins Sales by Application (2016-2021) & (K Units)
Table 83. Japan Hyperimmune Globulins Sales Market Share by Application (2016-2021)
Table 84. Japan Hyperimmune Globulins Sales by Application (2022-2027) & (K Units)
Table 85. Japan Hyperimmune Globulins Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Hyperimmune Globulins Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Hyperimmune Globulins Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Hyperimmune Globulins Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Hyperimmune Globulins Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Hyperimmune Globulins Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Hyperimmune Globulins Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Hyperimmune Globulins Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Hyperimmune Globulins Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Hyperimmune Globulins Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Hyperimmune Globulins Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Hyperimmune Globulins Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Hyperimmune Globulins Sales Market Share by Application (2022-2027)
Table 98. India Hyperimmune Globulins Sales (K Units) by Company (2016-2021)
Table 99. India Hyperimmune Globulins Sales Market Share by Company (2016-2021)
Table 100. India Hyperimmune Globulins Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Hyperimmune Globulins Revenue Market Share by Company (2016-2021)
Table 102. India Hyperimmune Globulins Sales by Type (2016-2021) & (K Units)
Table 103. India Hyperimmune Globulins Sales Market Share by Type (2016-2021)
Table 104. India Hyperimmune Globulins Sales by Type (2022-2027) & (K Units)
Table 105. India Hyperimmune Globulins Sales Market Share by Type (2022-2027)
Table 106. India Hyperimmune Globulins Sales by Application (2016-2021) & (K Units)
Table 107. India Hyperimmune Globulins Sales Market Share by Application (2016-2021)
Table 108. India Hyperimmune Globulins Sales by Application (2022-2027) & (K Units)
Table 109. India Hyperimmune Globulins Sales Market Share by Application (2022-2027)
Table 110. CSL Behring Corporation Information
Table 111. CSL Behring Description and Business Overview
Table 112. CSL Behring Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. CSL Behring Hyperimmune Globulins Product
Table 114. CSL Behring Recent Development
Table 115. Grifols Corporation Information
Table 116. Grifols Description and Business Overview
Table 117. Grifols Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Grifols Hyperimmune Globulins Product
Table 119. Grifols Recent Development
Table 120. Biotest Corporation Information
Table 121. Biotest Description and Business Overview
Table 122. Biotest Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Biotest Hyperimmune Globulins Product
Table 124. Biotest Recent Development
Table 125. Kedrion Corporation Information
Table 126. Kedrion Description and Business Overview
Table 127. Kedrion Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Kedrion Hyperimmune Globulins Product
Table 129. Kedrion Recent Development
Table 130. CBPO Corporation Information
Table 131. CBPO Description and Business Overview
Table 132. CBPO Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. CBPO Hyperimmune Globulins Product
Table 134. CBPO Recent Development
Table 135. Emergent (Cangene) Corporation Information
Table 136. Emergent (Cangene) Description and Business Overview
Table 137. Emergent (Cangene) Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Emergent (Cangene) Hyperimmune Globulins Product
Table 139. Emergent (Cangene) Recent Development
Table 140. Kamada Corporation Information
Table 141. Kamada Description and Business Overview
Table 142. Kamada Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Kamada Hyperimmune Globulins Product
Table 144. Kamada Recent Development
Table 145. CNBG Corporation Information
Table 146. CNBG Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. CNBG Description and Business Overview
Table 148. CNBG Hyperimmune Globulins Product
Table 149. CNBG Recent Development
Table 150. Hualan Bio Corporation Information
Table 151. Hualan Bio Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Hualan Bio Description and Business Overview
Table 153. Hualan Bio Hyperimmune Globulins Product
Table 154. Hualan Bio Recent Development
Table 155. Shanghai RAAS Corporation Information
Table 156. Shanghai RAAS Description and Business Overview
Table 157. Shanghai RAAS Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Shanghai RAAS Hyperimmune Globulins Product
Table 159. Shanghai RAAS Recent Development
Table 160. Sichuan Yuanda Shuyang Corporation Information
Table 161. Sichuan Yuanda Shuyang Description and Business Overview
Table 162. Sichuan Yuanda Shuyang Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Sichuan Yuanda Shuyang Hyperimmune Globulins Product
Table 164. Sichuan Yuanda Shuyang Recent Development
Table 165. ADMA Biologics Corporation Information
Table 166. ADMA Biologics Description and Business Overview
Table 167. ADMA Biologics Hyperimmune Globulins Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 168. ADMA Biologics Hyperimmune Globulins Product
Table 169. ADMA Biologics Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. Hyperimmune Globulins Distributors List
Table 173. Hyperimmune Globulins Customers List
Table 174. Hyperimmune Globulins Market Trends
Table 175. Hyperimmune Globulins Market Drivers
Table 176. Hyperimmune Globulins Market Challenges
Table 177. Hyperimmune Globulins Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Hyperimmune Globulins Product Picture
Figure 2. Global Hyperimmune Globulins Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Hyperimmune Globulins Sales Market Share by Application in 2021 & 2027
Figure 6. Government Institutions Examples
Figure 7. Private Sector Examples
Figure 8. Other Examples
Figure 9. Global Hyperimmune Globulins Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Hyperimmune Globulins Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Hyperimmune Globulins Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global Hyperimmune Globulins Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global Hyperimmune Globulins Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Hyperimmune Globulins Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Hyperimmune Globulins Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Hyperimmune Globulins Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe Hyperimmune Globulins Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Hyperimmune Globulins Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Hyperimmune Globulins Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Hyperimmune Globulins Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Hyperimmune Globulins Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Hyperimmune Globulins Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Hyperimmune Globulins Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Hyperimmune Globulins Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Hyperimmune Globulins Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Hyperimmune Globulins Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Hyperimmune Globulins Players Market Share by Revenue in Hyperimmune Globulins: 2016 & 2020
Figure 28. Hyperimmune Globulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Hyperimmune Globulins Revenue Share by Type (2016-2021)
Figure 30. Global Hyperimmune Globulins Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Hyperimmune Globulins Revenue Share by Application (2016-2021)
Figure 32. Global Hyperimmune Globulins Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Hyperimmune Globulins Sales Market Share by Type in 2020
Figure 34. North America Hyperimmune Globulins Sales Market Share by Application in 2020
Figure 35. Europe Hyperimmune Globulins Sales Market Share by Type in 2020
Figure 36. Europe Hyperimmune Globulins Sales Market Share by Application in 2020
Figure 37. China Hyperimmune Globulins Sales Market Share by Type in 2020
Figure 38. China Hyperimmune Globulins Sales Market Share by Application in 2020
Figure 39. Japan Hyperimmune Globulins Sales Market Share by Type in 2020
Figure 40. Japan Hyperimmune Globulins Sales Market Share by Application in 2020
Figure 41. Southeast Asia Hyperimmune Globulins Sales Market Share by Type in 2020
Figure 42. Southeast Asia Hyperimmune Globulins Sales Market Share by Application in 2020
Figure 43. India Hyperimmune Globulins Sales Market Share by Type in 2020
Figure 44. India Hyperimmune Globulins Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Hyperimmune Globulins
Figure 47. Manufacturing Process Analysis of Hyperimmune Globulins
Figure 48. Hyperimmune Globulins Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
皮下免疫グロブリンのグローバル市場2021 Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that do…- 世界の血漿誘導体市場規模・現状・予測（2021年-2027年） Blood plasma is the liquid component of blood constituting of water along with plasma components such as immunoglobulin, electrolytes, glucose, clotting factors, electrolytes, and hormones. It plays a crucial role in maintaining the electrolyte and osmotic balance while preventing infection and bloo…
- 狂犬病ワクチンのグローバル市場2021 Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus. Every year more than 5.5 million people have died for rabies, mostly in Asia and Africa. With…
- 世界の狂犬病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Rabies Treatment Market The global Rabies Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a b…
- 人間狂犬病免疫グロブリン（IM）のグローバル市場2021 Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure. Figure Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation …